Table 1.
General characteristics of gastric cancer cases and controls selected for the screening of 203 innate immunity- and 264 NHL-related candidate genes in the discovery, replication and pooled analyses.
Table 2.
The results in the Discovery phase: Innate immunity and NHL-related gene variants and risk of gastric cancer in the Illumina OPA.
Table 3.
The results of the pooled- and meta-analyses including the discovery and replication phases: Association of most significant SNPs in the innate immunity and NHL-related gene variants and gastric cancer risk.